Instantly injectable, thermo-stable vaccines at tropical temperatures could make cold storage problems a thing of the past

The pioneering technology is based on two main platforms – VitRIS (Vitrified Readily Injectable Suspension) and HydRIS® (Hypodermic Rehydration Injection System). Nova also owns what is believed to be the world’s only fully validated cGMP aseptic spray-dryer for the production of clinical material. The facility will accelerate the time to market of VitRIS- based products, writes John Seaton of Nova Bio-Pharma Technologies Ltd.

Read more